These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 6344562)

  • 1. Dopamine receptors in the central nervous system.
    Creese I; Sibley DR; Hamblin MW; Leff SE
    Adv Biochem Psychopharmacol; 1983; 36():125-34. PubMed ID: 6344562
    [No Abstract]   [Full Text] [Related]  

  • 2. Dopamine receptors in the central nervous system.
    Creese I; Morrow AL; Leff SE; Sibley DR; Hamblin MW
    Int Rev Neurobiol; 1982; 23():255-301. PubMed ID: 6749737
    [No Abstract]   [Full Text] [Related]  

  • 3. Detection of multiple receptors for dopamine.
    Spano PF; Memo M; Stefanini E; Fresia P; Trabucchi M
    Adv Biochem Psychopharmacol; 1980; 21():243-51. PubMed ID: 7376971
    [No Abstract]   [Full Text] [Related]  

  • 4. Multiple receptors for serotonin in the rat brain.
    Hamon M; Nelson DL; Herbet A; Glowinski J
    Adv Biochem Psychopharmacol; 1980; 21():223-33. PubMed ID: 7376970
    [No Abstract]   [Full Text] [Related]  

  • 5. Thermodynamic differences between agonist and antagonist interactions with binding sites for [3H]spiroperidol in rat striatum.
    Zahniser NR; Molinoff PB
    Mol Pharmacol; 1983 Mar; 23(2):303-9. PubMed ID: 6835199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are striatal [3H]spiperone radioreceptor assays indicative of multiple dopamine receptor interactions?
    Clements-Jewery S; Robson PA
    Neuropharmacology; 1981 Dec; 20(12B):1295-8. PubMed ID: 7322304
    [No Abstract]   [Full Text] [Related]  

  • 7. Dopamine receptors: subtypes, localization and regulation.
    Creese I; Sibley DR; Leff S; Hamblin M
    Fed Proc; 1981 Feb; 40(2):147-52. PubMed ID: 7007083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three classes of dopamine receptor (D-2, D-3, D-4) identified by binding studies with 3H-apomorphine and 3H-domperidone.
    Sokoloff P; Martres MP; Schwartz JC
    Naunyn Schmiedebergs Arch Pharmacol; 1980; 315(2):89-102. PubMed ID: 7207647
    [No Abstract]   [Full Text] [Related]  

  • 9. Agonist interactions with dopamine receptors: focus on radioligand-binding studies.
    Creese I; Sibley DR; Leff SE
    Fed Proc; 1984 Oct; 43(13):2779-84. PubMed ID: 6383871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimation of the apparent affinity of the striatal dopamine receptors for the radioligand[3H]spiperone [( 3H]spiroperidol).
    Hruska RE
    J Neurosci Res; 1984; 12(4):571-81. PubMed ID: 6512888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low density of dopamine D4 receptors in Parkinson's, schizophrenia, and control brain striata.
    Seeman P; Guan HC; Van Tol HH; Niznik HB
    Synapse; 1993 Aug; 14(4):247-53. PubMed ID: 8248849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurobiology of dopamine in schizophrenia.
    Guillin O; Abi-Dargham A; Laruelle M
    Int Rev Neurobiol; 2007; 78():1-39. PubMed ID: 17349856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dopaminergic receptors in the brain].
    Alexandrová M
    Cesk Fysiol; 1984; 33(3):227-40. PubMed ID: 6147203
    [No Abstract]   [Full Text] [Related]  

  • 14. Increased 3H-spiperone binding sites in mesolimbic area related to methamphetamine-induced behavioral hypersensitivity.
    Akiyama K; Sato M; Otsuki S
    Biol Psychiatry; 1982 Feb; 17(2):223-31. PubMed ID: 7200378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of dopamine receptor sites labeled by [3H]-S-sulpiride and [3H]-spiperone in striatum.
    Zahniser NR; Dubocovich ML
    J Pharmacol Exp Ther; 1983 Dec; 227(3):592-9. PubMed ID: 6655559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of [3H]pergolide mesylate to dopamine receptors of mammalian brains.
    Wong DT; Bymaster FP; Lane PT; Kau D; Bach NJ; Kornfeld EC
    Res Commun Chem Pathol Pharmacol; 1980 Nov; 30(2):195-210. PubMed ID: 7444158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of long-term treatment with haloperidol and sulpiride on different types of dopaminergic receptors.
    Trabucchi M; Memo M; Battaini F; Reggiani A; Spano PF
    Adv Biochem Psychopharmacol; 1980; 24():275-81. PubMed ID: 7405667
    [No Abstract]   [Full Text] [Related]  

  • 18. Adenosine receptors and Parkinson's disease. Relevance of antagonistic adenosine and dopamine receptor interactions in the striatum.
    Fuxe K; Strömberg I; Popoli P; Rimondini-Giorgini R; Torvinen M; Ogren SO; Franco R; Agnati LF; Ferré S
    Adv Neurol; 2001; 86():345-53. PubMed ID: 11553995
    [No Abstract]   [Full Text] [Related]  

  • 19. Specific binding of [(11)C]raclopride and N-[(3)H]propyl-norapomorphine to dopamine receptors in living mouse striatum: occupancy by endogenous dopamine and guanosine triphosphate-free G protein.
    Cumming P; Wong DF; Gillings N; Hilton J; Scheffel U; Gjedde A
    J Cereb Blood Flow Metab; 2002 May; 22(5):596-604. PubMed ID: 11973432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Responses induced by dopamine in Xenopus laevis oocytes injected with mRNA from heat injured rat striatum].
    Zhao YQ; Zhang BL; Wang LM; Xing C; Li M; Fan M
    Sheng Li Xue Bao; 2000 Aug; 52(4):287-9. PubMed ID: 11951108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.